Farnesoid X receptor modulators
US10532061B2 · kind B2 · utility
3Cited by
2References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 6, 2018 |
| Grant date | Jan 14, 2020 |
| Priority date | — |
| Expiry date | Sep 6, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J71/001
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of formula (I): or a pharmaceutically acceptable salt, solvate, or amino acid conjugate thereof, wherein R1, R2, R3, R4, R5, and R6 are as described herein. The present invention relates generally to selective FXR agonists and to methods of making and using them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.